Human Immunodeficiency Virus (HIV)
Human immunodeficiency virus (HIV) is an infectious disease that attacks the human body’s immune system. If left untreated, the virus can lead to acquired immunodeficiency syndrome (AIDS). Over time, HIV destroys CD4 cells, a key infection-fighting cell. Without a sufficient number of CD4 cells, the immune system becomes weakened and can no longer effectively fight off infections. Within VA, HIV research focuses on testing, prevention, and delivery of care to Veterans with HIV.
Each "widget" below is populated by a dynamic search of the HSR&D website and its underlying databases. Search results are generated based on the search term "HIV". Results are updated regularly, as new data are available.
VIEW: Citations | Publication Briefs | Studies | HSR&D Briefs, Reports, Newsletters | Topic Spotlight | Cyberseminars | Videos | Podcasts | Other Resources
(5 of more than 1488 HIV focused publications)
- Barry MP, Austin EJ, Bhatraju EP, Glick SN, Stekler JD, Tung EL, Hansen RN, Williams EC, Gojic AJ, Pickering EI, Tsui JI. Qualitative inquiry into perceptions of HIV pre-exposure prophylaxis among people who inject drugs living with hepatitis C in Seattle, WA, USA. Harm reduction journal. 2022 Nov 1; 19(1):121.
- Edelman EJ, Gan G, Dziura J, Esserman D, Porter E, Becker WC, Chan PA, Cornman DH, Helfrich CD, Reynolds J, Yager JE, Morford KL, Muvvala SB, Fiellin DA. Effect of Implementation Facilitation to Promote Adoption of Medications for Addiction Treatment in US HIV Clinics: A Randomized Clinical Trial. JAMA Network Open. 2022 Oct 3; 5(10):e2236904.
- Davy-Mendez T, Sarovar V, Levine-Hall T, Lea AN, Sterling SA, Chi FW, Palzes VA, Luu MN, Flamm JA, Hare CB, Williams EC, Bryant KJ, Weisner CM, Silverberg MJ, Satre DD. Characterizing Unhealthy Alcohol Use Patterns and Their Association with Alcohol Use Reduction and Alcohol Use Disorder During Follow-Up in HIV Care. AIDS and behavior. 2022 Sep 28.
- Edwards GG, Miyashita-Ochoa A, Castillo EG, Goodman-Meza D, Kalofonos I, Landovitz RJ, Leibowitz AA, Pulsipher C, El Sayed E, Shoptaw S, Shover CL, Tabajonda M, Yang YS, Harawa NT. Long-Acting Injectable Therapy for People with HIV: Looking Ahead with Lessons from Psychiatry and Addiction Medicine. AIDS and behavior. 2022 Sep 5.
- Bingaman AR, Hamilton AB, Olivero R, Crowell CS, Fair CD. Literally the hardest part about having a positive child is disclosure": Child and family stigma management strategies among U.S. parents of internationally adopted children with perinatally-acquired HIV. SSM. Qualitative research in health. 2022 Jul 11; 2(100122):doi.org/10.1016/j.ssmqr.2022.100122.
» View more Citations
(5 of more than 22 HIV focused publication briefs)
- VA Successfully Implements Interferon-free Treatment for Hepatitis C Virus in Previously Undertreated Patient Populations
This study examined the adoption of interferon-free treatment for hepatitis C virus (HCV) in VA to learn who received this therapy and whether the limitations of interferon-containing treatments have been overcome, including low rates of use among VA healthcare users who are African American or Hispanic, and among those with HCV-HIV co-infection. Findings showed that with the advent of interferon-...
Date: March 7, 2018
- Evidence Review Identifies Modest Mortality Disparities among Racial and Ethnic Minority Groups in VA Healthcare
To support VA’s efforts to better understand the scale and determinants of disparities in racial and ethnic mortality – and to develop interventions to reduce disparities, investigators from the VA Evidence-based Synthesis Program (ESP) Coordinating Center in Portland, OR conducted an evidence review of mortality disparities specific to VA. Findings showed that although VA’s equal access healthcar...
Date: March 1, 2018
- Racial Disparities in HIV Quality of Care that May Extend to Common Comorbid Conditions
To more fully understand patterns of racial disparities in the quality of care for persons with HIV infection, this study examined a national cohort of Veterans in care for HIV in the VA healthcare system during 2013. Findings showed that racial disparities were identified in quality of care specific to HIV infection – and in the care of common comorbid conditions. Blacks were less likely than whi...
Date: September 22, 2016
- New Guidelines May Significantly Decrease Cost for Testing Immune Function in Veterans with HIV
In 2012, the Department of Health and Human Services recommended CD4 testing in patients with HIV every 3 to 6 months – except in patients with consistently suppressed virus and sustained CD4 cell count, who could be tested every 6 to 12 months. In 2014, updated guidelines recommended that in individuals with viral suppression, CD4 testing be considered either optional or annual, depending on the ...
Date: July 1, 2016
- Consequences of Notifying VA Patients about Potential Exposure to Large-Scale Adverse Events
This study sought to determine the intended and unintended consequences of patient notification following a large-scale adverse event (LSAE) within the VA healthcare system, which systematically looks for LSAEs, tracks potentially exposed patients, and communicates with them after LSAE notification. Findings showed that more than two-thirds of potentially exposed patients returned for HCV, HBV, an...
Date: May 1, 2015
» View more Publication Briefs
( 5 of more than 80 HIV focused projects
|| A nurse-led intervention to extend the Veteran HIV treatment cascade for cardiovascular disease prevention (V-EXTRA-CVD)
|| HIV Translating Initiatives for Depression into Effective Solutions – Hyb
|| A Personalized mHealth Approach to Smoking Cessation for Veterans Living with HIV
|| A Patient-centered Approach to Comorbidity Management in Aging Veterans with HIV
|| Effectiveness of Telehealth Collaborative Care for Veterans with HIV in Ruraland Outlying Settings
» View more Studies
Read more on this topic and related topics
There are currently no videos for this topic.
There are currently no podcasts for this topic.